Astrana Health
ASTH
130 hedge funds and large institutions have $570M invested in Astrana Health in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 35 closing their positions.
2,906% more call options, than puts
Call options by funds: $8.33M | Put options by funds: $277K
43% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 37
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.49% less ownership
Funds ownership: 43.71% → 43.23% (-0.49%)
16% less funds holding
Funds holding: 154 → 130 (-24)
26% less capital invested
Capital invested by funds: $772M → $570M (-$202M)
63% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$11.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.24M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.55M |
| 4 |
Renaissance Technologies
New York
|
+$2.11M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.22M |
| 2 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$5.49M |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$4M |
| 4 |
Morgan Stanley
New York
|
-$3.8M |
| 5 |
Man Group
London,
United Kingdom
|
-$3.14M |
ASTH Hedge Fund Activity: Q4 2022 in Review
130 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q4 2022, worth a combined $570M — down 26% from $772M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of ASTH and 13 opened new positions — a net loss of 22 holders — while 37 trimmed existing stakes and 53 added.
The largest buyer was BlackRock, adding an estimated $11.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $9.22M sold.
- 130 institutional investors held Astrana Health (ASTH) as of Q4 2022, down from 154 in Q3 2022.
- Funds reported $570M of Astrana Health stock for Q4 2022, down 26% quarter-over-quarter.
- 13 funds opened new Astrana Health positions in Q4 2022 and 35 closed out, a net change of -22 holders.
- The largest Astrana Health buyer in Q4 2022 was BlackRock, an estimated $11.8M added.
- The largest Astrana Health seller in Q4 2022 was Point72 Asset Management, an estimated $9.22M sold.
Based on aggregated 13F filings for Q4 2022.